Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.

International journal of chronic obstructive pulmonary disease(2023)

引用 0|浏览8
暂无评分
摘要
For COPD patients, ICS therapy offers some protection against progression to ICU admission and death among COVID-19 hospitalized patients. Our findings alleviate concerns about increased risks of COVID-19 by ICS treatment and provide evidence supporting the continuation of ICS therapy for COPD patients.
更多
查看译文
关键词
COVID-19, COPD, mortality
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要